Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 020785 Product 001 in the OB_Rx list.


Patent Data

Appl
No
Prod
No
Patent
No
Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N020785 001 5629327 May 13, 2014 U - 731
N020785 001 6045501 Aug 28, 2018 U - 371
N020785 001 6045501 Aug 28, 2018 U - 731
N020785 001 6235756 Mar 1, 2013 U - 731
N020785 001 6315720 Oct 23, 2020 U - 442
N020785 001 6315720 Oct 23, 2020 U - 731
N020785 001 6561976 Aug 28, 2018 U - 371
N020785 001 6561976 Aug 28, 2018 U - 731
N020785 001 6561977 Oct 23, 2020 U - 371
N020785 001 6561977 Oct 23, 2020 U - 731
N020785 001 6755784 Oct 23, 2020 U - 371
N020785 001 6755784 Oct 23, 2020 U - 731
N020785 001 6869399 Oct 23, 2020 U - 371
N020785 001 6869399 Oct 23, 2020 U - 731
N020785 001 6869399 Oct 23, 2020 U - 732
N020785 001 6869399 Oct 23, 2020 U - 733
N020785 001 6908432 Aug 28, 2018 U - 371
N020785 001 6908432 Aug 28, 2018 U - 731
N020785 001 7141018 Oct 23, 2020 U - 371
N020785 001 7141018 Oct 23, 2020 U - 731
N020785 001 7141018 Oct 23, 2020 U - 732
N020785 001 7141018 Oct 23, 2020 U - 733
N020785 001 7230012 Dec 9, 2023 Y
N020785 001 7435745 Nov 3, 2017 U - 899
N020785 001 7723361 Mar 1, 2013 U - 1058
N020785 001 7874984 Aug 28, 2018 U - 1109
N020785 001 7874984 Aug 28, 2018 U - 371
N020785 001 7874984 Aug 28, 2018 U - 442
N020785 001 7874984 Aug 28, 2018 U - 732
N020785 001 7874984 Aug 28, 2018 U - 733
N020785 001 7959566 Oct 23, 2020 U - 1155
N020785 001 8143283 Mar 1, 2013 U - 1236
N020785 001 8204763 Aug 28, 2018 U - 1249
N020785 001 8315886 Oct 23, 2020 U - 1249

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N020785 001 ODE May 25, 2013



Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:
    Orange Book Data - Monthly
    Generic Drug Product Information & Patent Information - Daily
    Orange Book Data Updated Through May, 2013
    Patent and Generic Drug Product Data Last Updated: June 14, 2013
-
-